GlassScriptPhysician profile
Chaitanya R Divgi
NPI 1376520502
$2,216,147.27
in general payments reported to CMS, 2019-2025
9 companies · $5,000 in 2025
The $5,000 reported for 2025 was more than what 92% of Nuclear Medicine providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282K · 2020: $280K · 2021: $238K · 2022: $413K · 2023: $918K · 2024: $80K · 2025: $5,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $991K · Travel and Lodging: $12K · Food and Beverage: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $990,940.00 |
| Travel and Lodging | $11,637.82 |
| Food and Beverage | $137.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Research & Development, LLC | $1,142,288.09 | 2019-2023 | |
| Reflexion Medical, INC. | $1,045,829.20 | 2020-2025 | Reflexion Medical Radiotherapy System |
| Ipsen Pharma Sas | $20,335.00 | 2019 | |
| Y-Mabs Therapeutics, INC. | $5,000.00 | 2021 | |
| Merck Sharp & Dohme LLC | $2,440.00 | 2023 | |
| Siemens Medical Solutions USA, INC. | $137.86 | 2023 | Biograph Vision 600 (8 Ring/64 Ct) |
| Astellas Pharma US INC | $70.38 | 2019 | |
| Janssen Global Services, LLC | $33.75 | 2020 | |
| Curium US LLC | $12.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chaitanya Divgi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.